Anonymous
Guest
Anonymous
Guest
If you had a failed fidelis/Riata/Durata you'd think differently. There are pts that refused endovascular implant that want this device. Also can you imagine if this had been around 7 or so years ago? Thousands of patients wouldn't be dealing with or wouldn't have dealt w these lead issues. that's just a couple of reasons. Once the next gen is released the acceptance will be even greater.
So the company with the best track record for cardiac leads (Reliance) are going to try to sell a "leadless" system with no reliability data, no ATP pacing and high complication rate?
Bsc is in a tough spot.